3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Conditions
Myelodysplastic Syndromes
2
Leukemia, Myeloid, Acute
2
Recurrence
1
Leukemia
1
Interventions
fludarabine phosphate
34
Cyclophosphamide
31
Peripheral Blood Stem Cell Transplantation
27
Mycophenolic Acid
25
Cyclosporine
23
Antilymphocyte Serum
23
Busulfan
20
Tacrolimus
17
Radiotherapy
17
Filgrastim
17
Whole-Body Irradiation
15
Methotrexate
15
Methylprednisolone
14
Melphalan
13
Cord Blood Stem Cell Transplantation
12
venetoclax
9
Cytarabine
8
Azacitidine
8
fludarabine
5
Etoposide
5
sargramostim
4
Therapeutics
4
Sirolimus
4
Decitabine
4
Clofarabine
4
Alemtuzumab
4
thymoglobulin
3
nilotinib
3
merphos
2
Voriconazole
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recurrence
×
Tranylcypromine
×
Myeloid
×
Clear all
NCT02717884
2018-10-18
TRANSATRA
University Hospital Freiburg
Phase 1/2
Unknown
60 enrolled